LAURA LOVE: Open Payments
NPI 1477188019 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,596 in 62 payments from 17 companies in 2025. Trend: 2023 $519 · 2024 $1,687 · 2025 $2,596
Food & beverage: $2,183Travel & lodging: $314Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $727 |
| Enterra Medical, Inc. | 2 | $669 |
| Janssen Biotech, Inc. | 6 | $403 |
| Pharmacosmos Therapeutics Inc. | 2 | $168 |
| Gilead Sciences, Inc. | 3 | $143 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 7 | $71 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
Products named: TREMFYA, SKYRIZI, RINVOQ, MONOFERRIC, XIFAXAN, Livdelzi, LINZESS, VOQUEZNA.
Industry payments across NC — which companies pay providers there.
